NSE: NIFTYPHARMA

21126.75 252.45 (1.21%)

NSE 17 Apr, 2025 3:31 PM (IST)

Nifty Pharma PB	5.2
Nifty Pharma PE	32.0
Nifty Pharma DIV	0.7
Nifty Pharma EPS	660

Nifty Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Nifty Pharma on BSE

Search Inside the pdf :

Abbott India Ltd.

18 Apr 2025, 05:01PM

30690.00

-0.07%

Company Update

Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Chief Financial Officer

Granules India Ltd.

18 Apr 2025, 04:58PM

467.50

0.96%

Company Update

Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Change in Management

J B Chemicals & Pharmaceuticals Ltd.

18 Apr 2025, 02:27PM

1646.30

1.12%

Company Update

JB Chemicals & Pharmaceuticals Ltd - 506943 - ANDA Approval By US FDA

BSE India

ANDA Approval by US FDA

Divi's Laboratories Ltd.

18 Apr 2025, 07:47AM

5640.00

-1.98%

Company Update

Divis Laboratories Ltd - 532488 - Intimation Of Signing Of Long-Term Manufacturing And Supply Agreement

BSE India

As per enclosed letter.

17 Apr 2025, 10:48PM

1515.20

1.26%

Company Update

Cipla Ltd - 500087 - Update On USFDA Inspection At Manufacturing Facility Of Medispray In Kundaim, …

BSE India

Update on USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India

Zydus Lifesciences Ltd.

17 Apr 2025, 07:44PM

831.55

1.15%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release

Glenmark Pharmaceuticals Ltd.

17 Apr 2025, 05:04PM

1342.40

-1.06%

Company Update

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Allotment of Equity Shares under the Glenmark Pharmaceuticals Limited Employee Stock Option Scheme, 2016

Zydus Lifesciences Ltd.

17 Apr 2025, 03:41PM

831.55

1.15%

Company Update

Zydus Lifesciences Ltd - 532321 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Details of an order passed in the litigation matter pertaining to validity of patent

17 Apr 2025, 03:01PM

1515.20

1.26%

Company Update

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 13th May, 2025.

17 Apr 2025, 02:42PM

1515.20

1.26%

Company Update

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 we hereby notify that the Operations and Administrative Committee of the Company on 17th April, 2025 has allotted 23,282 fully paid up equity shares of INR 2/- each pursuant to exercise of employee stock options under the Employee Stock Option Scheme 2013-A of the Company.

Is Nifty Pharma worth buying?

307 Votes:

Buy 79.15%

Sell 11.73%

Hold 9.12%